Antimicrobial resistance in isolates of Helicobacter pylori in a referral center.

被引:0
|
作者
Lopez-Vidal, Y [1 ]
Rangel-Frausto, MS [1 ]
Calva, JJ [1 ]
机构
[1] Univ Nacl Autonoma Mexico, Fac Med, Dept Microbiol, Mexico City, DF, Mexico
来源
REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION | 1998年 / 50卷 / 01期
关键词
Helicobacter pylori; antimicrobial resistance; metronidazole; Mexico;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. To estimate the frequency of H. pylori clinical isolates resistant to six commonly used antimicrobials. Design. Cross-sectional observational study. Setting. A tertiary-referral health care institution in Mexico City. Participants. 31 isolates of H. pylori from 31 patients with chronic antral gastritis were obtained from gastric mucosal biopsy specimens. Main outcome measure. The Minimum Inhibitory Concentration (MIC) to ampicillin, amoxycillin, tetracycline, doxycycline, metronidazole and to colloidal bismuth subcitrate was determined by the agar plate dilution test. Results. All isolates showed to be susceptible to the former four antibiotics but only in 46% and 55% growth was inhibited by 8 mu g/mL and 16 mu g/mL of metronidazole, respectively. All isolates were inhibited by less than or equal to 128 mu g/mL of bismuth. A 50% increase in the percentage of metronidazole-resistant isolates (MIC greater than or equal to mu g/mL) between 1988 to 1992 was observed. Conclusion. There is a need of future studies in our setting aimed at assessing the cost/effectiveness of diverse H. pylori-associated peptic ulcer treatment options.
引用
收藏
页码:19 / 24
页数:6
相关论文
共 50 条
  • [41] Mutations Related to Antibiotics Resistance in Helicobacter pylori Clinical Isolates from Bangladesh
    Fauzia, Kartika Afrida
    Aftab, Hafeza
    Tshibangu-Kabamba, Evariste
    Alfaray, Ricky Indra
    Saruuljavkhlan, Batsaikhan
    Cimuanga-Mukanya, Alain
    Matsumoto, Takashi
    Subsomwong, Phawinee
    Akada, Junko
    Miftahussurur, Muhammad
    Yamaoka, Yoshio
    ANTIBIOTICS-BASEL, 2023, 12 (02):
  • [42] rdxA gene is an unlikely marker for metronidazole resistance in the Asian Helicobacter pylori isolates
    Lui, SY
    Ling, KL
    Ho, B
    JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY, 2003, 13 (05) : 751 - 758
  • [43] Resistance rate to antibiotics of Helicobacter pylori isolates in eastern Taiwan
    Hu, Chi-Tan
    Wu, Chao-Chuan
    Lin, Chih-Yung
    Cheng, Chuan-Chu
    Su, Siou-Cing
    Tseng, Yi-Hsiung
    Lin, Nien-Tsung
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2007, 22 (05) : 720 - 723
  • [44] Antimicrobial susceptibility of Helicobacter pylori isolates from Lower Silesia, Poland
    Biernat, Monika Maria
    Poniewierka, Elzbieta
    Blaszczuk, Jerzy
    Czapla, Leszek
    Kempinski, Radoslaw
    Ksiadzyna, Dorota
    Grabinska, Joanna
    Binkowska, Aldona
    Megraud, Francis
    Gosciniak, Grazyna
    ARCHIVES OF MEDICAL SCIENCE, 2014, 10 (03) : 505 - 509
  • [45] Prevalence of antibiotic resistance of Helicobacter pylori isolates in Shanghai, China
    Wang, Jing
    Xie, Xiaolan
    Zhong, Zishao
    Yuan, Haipeng
    Xu, Ping
    Gao, Hengjun
    Lai, Yuexing
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2022, 14 (11): : 7831 - +
  • [46] Clarithromycin Resistance Patterns in Russian Helicobacter pylori Clinical Isolates
    Starkova, Daria
    Gladyshev, Nikita
    Polev, Dmitrii
    Svarval, Alena
    BIOMEDICAL AND BIOTECHNOLOGY RESEARCH JOURNAL, 2024, 8 : S40 - S40
  • [47] Unraveling antimicrobial resistance in Helicobacter pylori: Global resistome meets global phylogeny
    Domanovich-Asor, Tal
    Craddock, Hillary A.
    Motro, Yair
    Khalfin, Boris
    Peretz, Avi
    Moran-Gilad, Jacob
    HELICOBACTER, 2021, 26 (02)
  • [48] Advantages of Whole Genome Sequencing in Mitigating the Helicobacter pylori Antimicrobial Resistance Problem
    Fauzia, Kartika Afrida
    Alfaray, Ricky Indra
    Yamaoka, Yoshio
    MICROORGANISMS, 2023, 11 (05)
  • [49] The relationship between consumption of antimicrobial agents and the prevalence of primary Helicobacter pylori resistance
    Aldana, LP
    Kato, M
    Nakagawa, S
    Kawarasaki, M
    Nagasako, T
    Mizushima, T
    Oda, H
    Kodaira, J
    Shimizu, Y
    Komatsu, Y
    Zheng, R
    Takeda, H
    Sugiyama, T
    Asaka, M
    HELICOBACTER, 2002, 7 (05) : 306 - 309
  • [50] Development of Helicobacter pylori treatment: How do we manage antimicrobial resistance?
    Suzuki, Sho
    Esaki, Mitsuru
    Kusano, Chika
    Ikehara, Hisatomo
    Gotoda, Takuji
    WORLD JOURNAL OF GASTROENTEROLOGY, 2019, 25 (16) : 1907 - 1912